Overview of Biotech Capital Markets Through Week Ended February 24th

Let's take a look at some highlights from the Biotech and MedTech/Diagnostics Private and Public Capital Markets and SPAC Activity Through the Week Ended February 24th, 2023.

2023 YTD

• Biotech: 6 Transactions (3 Follow-Ons, 2 PIPEs, and 1 Registered Direct) totaling just over $600 Million

• Med Tech: 1 Transaction (1 Follow-On) totaling just under $50 Million

Week Ending February 24th, 2023

• 28 Biotech transactions totaling just over $2.9 Billion v. 2022: 15 Biotech transactions totaling just over $1.9 Billion

• 6 Med Tech transactions totaling just over $600 Million v. 2022: 1 Med Tech transaction just under $30 Million

Private Transactions

• Biotech: 30 US Transactions / 11 European Transaction

• Med Tech: 23 US Transactions / 6 European Transaction

What is going on in the capital market: